Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Nutriventia Private Limited currently has 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These matters are distributed across 2 distinct examiners and 2 distinct art units. This distribution indicates that the company is engaging with multiple specialized examination groups for its current patent applications. The presence of 2 distinct art units suggests that the company's innovations fall into different specialized categories within the biotechnology sector.
The busiest examiner identified in the data is TIEN, LUCY MINYU, who is handling 1 pending office action. Since the 2 pending office actions are split between 2 distinct examiners, the workload is evenly divided, and no single examiner dominates the current prosecution landscape. Practitioners should monitor the progress of these 2 pending office actions closely, as the 2 distinct examiners may apply different standards or focus on different aspects of the technology. Successfully navigating this portfolio requires a strategy that addresses the specific feedback from each of the 2 distinct examiners while maintaining a cohesive overall patent strategy. Studying the past behavior of TIEN, LUCY MINYU is essential for the 1 pending office action under their review.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| Multi-statute (no §101) | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TIEN, LUCY MINYU | 1 | 59.3% | +39.2% |
| JOSEPH, JANET | 1 | 40.0% | +51.3% |
| SILVERMAN, JANICE Y | 1 | 36.7% | +53.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18257160 | STABLE PROLONGED RELEASE FORMULATION OF VITAMIN C AND A PROCESS FOR PREPARATION THEREOF | TIEN, LUCY MINYU | — |
| 18002440 | PROLONGED RELEASE FORMULATION OF CAFFEINE | SILVERMAN, JANICE Y | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18250782 | MODIFIED RELEASE COMPOSITIONS COMPRISING MELATONIN | JOSEPH, JANET | 21d |
| 18257160 | STABLE PROLONGED RELEASE FORMULATION OF VITAMIN C AND A PROCESS FOR PREPARATION THEREOF | TIEN, LUCY MINYU | — |
| 18002440 | PROLONGED RELEASE FORMULATION OF CAFFEINE | SILVERMAN, JANICE Y | — |
| Art Unit | Apps |
|---|---|
| 1612 | 1 |
| 1611 | 1 |
| 1792 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18257160 | STABLE PROLONGED RELEASE FORMULATION OF VITAMIN C AND A PROCESS FOR PREPARATION THEREOF | TIEN, LUCY MINYU | 1612 | §103§112 | Non-Final OA | — | Pending | Jun 13, 2023 |
| 18250782 | MODIFIED RELEASE COMPOSITIONS COMPRISING MELATONIN | JOSEPH, JANET | 1611 | §103 | Final Rejection | 21d | Pending | Apr 27, 2023 |
| 18002440 | PROLONGED RELEASE FORMULATION OF CAFFEINE | SILVERMAN, JANICE Y | 1792 | §103§112 | Final Rejection | — | Pending | Dec 19, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial